SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,132.81 -382.62
( -0.50%)

Global Indices

Nasdaq

53,423.66 -283.45
(-0.53%)

Dow Jones

7,737.34 -31.37
(-0.40%)

Hang Seng

66,225.50 1,204.56
(1.85%)

Nikkei 225

10,828.70 -2.82
(-0.03%)

Forex

USD-INR

94.48 -0.24
(-0.26%)

EUR-INR

109.71 0.00
(0.00%)

GBP-INR

127.63 -0.19
(-0.15%)

JPY-INR

0.60 0.01
(1.60%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Neuland Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524558

INE794A01010

1453.5915229

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NEULANDLAB

58.48

29051.1

EPS(TTM)

Face Value()

Div & Yield %

387.19

0.15

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	2022.99	1476.84	1558.58	1191.20	951.08	936.91
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	2022.99	1476.84	1558.58	1191.20	951.08	936.91
Other Income	30.16	96.91	12.54	9.75	2.08	16.09
Stock Adjustments	64.26	-12.83	55.14	9.51	15.41	1.24
Total Income	2117.41	1560.92	1626.26	1210.46	968.57	954.24
EXPENDITURE :
Raw Materials	823.89	578.45	636.49	491.98	441.79	443.04
Power & Fuel Cost	58.14	50.56	48.72	48.62	42.21	39.21
Employee Cost	328.82	261.40	248.53	194.84	175.76	144.02
Other Manufacturing Expenses	129.35	108.66	103.73	82.69	84.92	73.71
Selling & Administrative Expenses	154.17	120.52	104.29	88.50	70.50	79.80
Miscellaneous Expenses	19.63	22.11	10.04	22.77	9.12	11.93
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1514.00	1141.71	1151.81	929.40	824.29	791.71
Operating Profit	603.41	419.22	474.47	281.06	144.27	162.54
Interest	23.95	8.30	14.00	13.07	13.49	17.90
Gross Profit	579.46	410.92	460.47	267.99	130.78	144.64
Depreciation	91.73	65.54	59.70	52.78	49.04	39.68
Profit Before Tax	487.73	345.38	400.77	215.21	81.74	104.96
Tax	128.88	73.65	99.59	50.39	20.42	12.48
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-4.26	12.29	1.59	1.70	-2.22	12.18
Reported Net Profit	363.11	259.43	299.60	163.12	63.53	80.29
Extraordinary Items	2.88	86.29	-0.30	-0.66	-1.36	9.81
Adjusted Net Profit	360.23	173.14	299.90	163.78	64.89	70.48
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	988.77	747.31	460.54	303.84	244.15	166.42
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	15.40	17.96	12.83	6.41	3.85	2.57
P & L Balance carried down	1336.48	988.77	747.31	460.54	303.84	244.15
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	340.00	120.00	140.00	100.00	50.00	50.00
Dividend Per Share(Rs)	34.00	12.00	14.00	10.00	5.00	5.00
Earnings Per Share-Unit Curr	281.47	201.10	232.24	126.44	49.25	62.24
Earnings Per Share(Adj)-Unit Curr	281.47	201.10	232.24	126.44	49.25	62.24
Book Value-Unit Curr	1445.69	1175.89	988.88	765.49	647.06	605.44
Book Value(Adj)-Unit Curr	1445.69	1175.89	988.88	765.49	647.06	605.44

76,132.81 -382.62 ( -0.50%)

53,423.66 -283.45 (-0.53%)

7,737.34 -31.37 (-0.40%)

66,225.50 1,204.56 (1.85%)

10,828.70 -2.82 (-0.03%)

94.48 -0.24 (-0.26%)

109.71 0.00 (0.00%)

127.63 -0.19 (-0.15%)

0.60 0.01 (1.60%)